BIOPIX-T announced that the portable molecular diagnostic platform “PEBBLE” as well as the compatible diagnostic test for coronavirus, are now commercially available upon notification to the EOF (Greek National Organization for Medicines).

This device is based on research conducted by BIOPIX-T executives at the Institute of Molecular Biology and Biotechnology of the Foundation for Research and Technology – Hellas (IMBB-FORTH) in Crete and perfected within the company, which is based in the Science and Technology Park of Crete (STEP-C).

George Papadakis who leads the company said: “I am very proud of the BIOPIX-T team which has managed, with a lot of hard work and in a really short time, to bring a technology out of the lab and offer it as a functional and reliable product in the market.”

For more, please visit the following link

https://biopix-t.com/news/biopix-t-launches-its-portable-molecular-diagnostic-device-pebble-with-the-covid19-test-for-the-point-of-care/

BIOPIX-T announced that the portable molecular diagnostic platform “PEBBLE” as well as the compatible diagnostic test for coronavirus, are now commercially available upon notification to the EOF (Greek National Organization for Medicines). For more, please go to our News menu.

Prof. Electra Gieli will be a Keyneote speaker in the 2nd International Electronic Conference on Biosensors, to be held virtually at 14-18 February 2022.

Prof. E. Gizeli will give the Plenary lecture in the International workshop organized within the framework of SAFEMILK project under Horizon 2020 (MSCA-RISE-2020) entitled: “Acoustic methods in the study of affinity interaction at surfaces“.

Prof. Gizeli participates in the newly funded proposal “CROPID: A digital ID for safe cereal crops in the agrifood sector”. The project, funded through H2020- DIH-WORLD Call, is coordinated by AgroApps SME. FORTH partner participates through Biosensors Lab and Plant Molecular Biology Lab (Prof. Kalantidis) to assist with the development of molecular assays for plant-borne pathogens.

E. Gizeli participated in three web-conferences as invited speaker.

1. at the 18th National Congress of the Greek Society of Clinical Chemistry and Biochemistry Conference on 15-17 October 2020;
2. at the 1st EFLM/AFCB Conference on Laboratory Medicine for Mobile Societies (LM4MS) on 18-20 February 2021

(both conferences were organised under the auspices of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC);

3. Nanotexnology 2021: International Conference on Nano-technologies, Organic Electronics and Nanomedicine (abstract).

Biosensors Lab receives funding from HFRI under the 4th call for “Interventions to address the economic and social consequences of the COVID-19 pandemic”.

Biosensors Lab received funding to develop a rapid diagnostic tool for COVID-19 antibodies detection directly in patients samples. The project, which has a duration of 12 months, will be carried out in collaboration with clinical partners at the Univ. of Crete.

The Human Frontier Science Program posts our recent publication on “Hybrid Sensor Device for Simultaneous Surface Plasmon Resonance and Surface Acoustic Wave Measurements” that appeared in Sensors 2020, Vol 20, pp. 6177, in the HFSP News and Events.

Prof. Electra Gizeli interviewed at “Kathimetini” about the rapid COVID-19 test developed in Biosensors’ lab (check News menu for more).